CONFIDENTIAL December 16, 2022 Michael WyzgaKineta, Inc./De • December 22nd, 2022 • Pharmaceutical preparations
The purpose of this letter agreement (the “Agreement”) is to confirm the terms of your separation of employment from Yumanity Therapeutics, Inc. and its subsidiaries (the “Company”) upon the Closing, as such term is defined in the Agreement and Plan of Merger, dated as of June 5, 2022, by and among Company and Kineta, Inc. (the “Merger Agreement”).
CONFIDENTIAL December 16, 2022 Richard Peters, M.D., Ph.D.Kineta, Inc./De • December 22nd, 2022 • Pharmaceutical preparations
The purpose of this letter agreement (the “Agreement”) is to confirm the terms of your separation from employment with Yumanity Therapeutics, Inc. and its subsidiaries (the “Company”) upon the Closing, as such term is defined in the Agreement and Plan of Merger, dated as of June 5, 2022, by and among Company and Kineta, Inc. (the “Merger Agreement”).
